Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8446340 | European Journal of Cancer | 2012 | 11 Pages |
Abstract
Plasma methoxytyramine is a novel biomarker for metastatic PPGLs that together with SDHB mutation status, tumour size and location provide useful information to assess the likelihood of malignancy and manage affected patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Graeme Eisenhofer, Jacques W.M. Lenders, Gabriele Siegert, Stefan R. Bornstein, Peter Friberg, Dragana Milosevic, Massimo Mannelli, W. Marston Linehan, Karen Adams, Henri J. Timmers, Karel Pacak,